-
Healthy Habits
A Protein PuzzleStudy links higher protein consumption to a greater chance of cancer death, but risk may depend on age.
by Alanna Kennedy-Gorman
-
Using Old Drugs in New Ways
We already reduce, reuse and recycle. But cancer researchers are exploring a fourth R–repurpose–using drugs approved for treating other diseases to reduce cancer risk and improve outcomes.
by Stephen Ornes
-
Unleashing the Immune System
New treatments that harness the power of the immune system are taking aim at many common cancers.
by Alexandra Goho
-
Editor's Letter
The Promise of ImmunotherapyImmunotherapy is a breakthrough in cancer treatment, but more research is needed to broaden its impact.
by Kevin McLaughlin
-
Forward Look
Unraveling the Genetics of CancerQ&A with Li Ding on The Cancer Genome Atlas
by Yasmine Iqbal
-
Forward Look
An Herbal SurpriseWhat's inside the herbal supplement may not match what's on the label.
by Stephen Ornes
-
Forward Look
Gut ReactionNew research suggests a link between gut bacteria and colorectal cancer.
by Melissa Weber
-
Forward Look
Affordable Care Act to Cover Breast Cancer Risk Reduction DrugsMedications are an option for high-risk women, but few use them.
by Sue Rochman
-
Forward Look
Push Needed to Increase HPV Vaccination RatesPresident's Cancer Panel stresses reducing 'missed opportunities.'
by Sue Rochman
-
Forward Look
Moving Closer to a Menthol Ban?FDA weighs whether to prohibit sales of mentholated tobacco products.
by Sharon Reynolds
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff